Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;182(6):1490-1492.
doi: 10.1111/bjd.18818. Epub 2020 Jan 29.

Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event

N Shukla  1 , M Paul  1 , M Halley  2   3 , M A Lowes  4 , V Hester  5 , C Aguilar  6 , S Guilbault  7 , T S Long  6 , A Taylor  6 , A C Thompson  6 , C A Yannuzzi  6 , E Linos  3 , H B Naik  1
Affiliations

Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event

N Shukla et al. Br J Dermatol. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M.A.L. has received fees for participating in advisory boards for AbbVie and Janssen, and consulting fees from Incyte, BSN and XBiotech, and Almirall; however, there is no conflict with the present study. H.B.N. has received grant funding from AbbVie and consulting fees from 23andme. H.B.N. and M.A.L. are Hidradenitis Suppurativa Foundation board members. C.A. receives patient referral fees from M3 Global Research.

References

    1. Saunte DM, Boer J, Stratigos A et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol 2015; 173:1546–9. - PubMed
    1. Alikhan A, Sayed C, Alavi A et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol 2019; 81:76–90. - PMC - PubMed
    1. Zouboulis CC, Desai N, Emtestam L et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29:619–44. - PubMed
    1. Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA 2017; 318:2019–32. - PubMed
    1. Naik HB, Lowes MA. A call to accelerate hidradenitis suppurativa research and improve care – moving beyond burden. JAMA Dermatol 2019; 155:1005–6. - PMC - PubMed

Publication types

MeSH terms